Fingerprint
Dive into the research topics of 'Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John Lachin, D Fitchett, Erich Bluhmki, Stefan Hantel, M Mattheus, Theresa Devins, Odd Johansen, H J Woerle, Joseph Selvanayagam
Research output: Contribution to journal › Article › peer-review
7255
Citations
(Scopus)